EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 263 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2020. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $522 | -54.3% | 153,524 | -1.3% | 0.00% | 0.0% |
Q2 2023 | $1,143 | -39.7% | 155,542 | -14.9% | 0.00% | -66.7% |
Q1 2023 | $1,894 | -24.8% | 182,772 | -14.3% | 0.00% | 0.0% |
Q4 2022 | $2,518 | -99.9% | 213,237 | +14.2% | 0.00% | -50.0% |
Q3 2022 | $3,918,000 | -74.1% | 186,676 | -61.8% | 0.01% | -70.0% |
Q2 2022 | $15,151,000 | -28.0% | 488,124 | -4.7% | 0.02% | -9.1% |
Q1 2022 | $21,037,000 | -3.3% | 512,344 | +2.3% | 0.02% | 0.0% |
Q4 2021 | $21,763,000 | -21.6% | 500,634 | -9.7% | 0.02% | -26.7% |
Q3 2021 | $27,745,000 | -13.4% | 554,121 | +9.0% | 0.03% | -9.1% |
Q2 2021 | $32,026,000 | -7.9% | 508,429 | +35.9% | 0.03% | -13.2% |
Q1 2021 | $34,755,000 | +6.0% | 374,075 | +2.3% | 0.04% | +2.7% |
Q4 2020 | $32,775,000 | -7.0% | 365,796 | +7.3% | 0.04% | -14.0% |
Q3 2020 | $35,242,000 | +31.5% | 341,061 | +0.6% | 0.04% | +26.5% |
Q2 2020 | $26,809,000 | -23.1% | 339,015 | -43.7% | 0.03% | -34.6% |
Q1 2020 | $34,842,000 | +46.7% | 602,181 | +36.8% | 0.05% | +85.7% |
Q4 2019 | $23,756,000 | +17.5% | 440,338 | +13.9% | 0.03% | +7.7% |
Q3 2019 | $20,216,000 | +5.3% | 386,683 | -2.7% | 0.03% | +8.3% |
Q2 2019 | $19,205,000 | +232.4% | 397,534 | +247.6% | 0.02% | +242.9% |
Q1 2019 | $5,778,000 | +26.9% | 114,369 | +48.9% | 0.01% | 0.0% |
Q4 2018 | $4,554,000 | -18.0% | 76,818 | -8.9% | 0.01% | 0.0% |
Q3 2018 | $5,551,000 | +19.5% | 84,318 | -8.4% | 0.01% | +16.7% |
Q2 2018 | $4,645,000 | +14.7% | 92,004 | +19.7% | 0.01% | +20.0% |
Q1 2018 | $4,048,000 | +51.5% | 76,881 | +33.7% | 0.01% | +66.7% |
Q4 2017 | $2,672,000 | +8.0% | 57,510 | -6.0% | 0.00% | 0.0% |
Q3 2017 | $2,474,000 | -26.1% | 61,166 | -38.1% | 0.00% | -25.0% |
Q2 2017 | $3,349,000 | +33.5% | 98,770 | +14.3% | 0.00% | +33.3% |
Q1 2017 | $2,509,000 | -40.8% | 86,390 | -33.1% | 0.00% | -50.0% |
Q4 2016 | $4,238,000 | +22.5% | 129,042 | +17.6% | 0.01% | +20.0% |
Q3 2016 | $3,459,000 | +66.2% | 109,712 | +48.2% | 0.01% | +66.7% |
Q2 2016 | $2,081,000 | -11.8% | 74,005 | +14.0% | 0.00% | -25.0% |
Q1 2016 | $2,360,000 | -7.1% | 64,916 | +2.2% | 0.00% | 0.0% |
Q4 2015 | $2,541,000 | +27.6% | 63,516 | -9.2% | 0.00% | +33.3% |
Q3 2015 | $1,992,000 | -56.7% | 69,916 | -50.0% | 0.00% | -57.1% |
Q2 2015 | $4,603,000 | +108.1% | 139,706 | +81.7% | 0.01% | +133.3% |
Q1 2015 | $2,212,000 | +33.6% | 76,907 | +26.5% | 0.00% | +50.0% |
Q4 2014 | $1,656,000 | +27.8% | 60,800 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $1,296,000 | -17.0% | 60,800 | -12.5% | 0.00% | 0.0% |
Q2 2014 | $1,561,000 | -9.8% | 69,500 | +1.5% | 0.00% | -33.3% |
Q1 2014 | $1,731,000 | +9.9% | 68,500 | 0.0% | 0.00% | +50.0% |
Q4 2013 | $1,575,000 | +39.1% | 68,500 | +15.3% | 0.00% | 0.0% |
Q3 2013 | $1,132,000 | +32.1% | 59,400 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $857,000 | – | 59,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |